(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of 389.61% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.45%.
Nautilus Biotechnology's revenue in 2026 is $190,000.On average, 4 Wall Street analysts forecast NAUT's revenue for 2026 to be $90,860,229, with the lowest NAUT revenue forecast at $62,355,059, and the highest NAUT revenue forecast at $120,256,186. On average, 4 Wall Street analysts forecast NAUT's revenue for 2027 to be $992,972,505, with the lowest NAUT revenue forecast at $598,608,569, and the highest NAUT revenue forecast at $1,402,988,834.
In 2028, NAUT is forecast to generate $3,089,247,794 in revenue, with the lowest revenue forecast at $2,968,100,821 and the highest revenue forecast at $3,180,108,023.